San Diego-based mostly Viking Therapeutics marked itself as a serious competitor during the weight loss drug market place in February following revealing promising information from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when offered as being a weekly injection and in March th… Read More